The aHUS Alliance has announced the release of its new overview on the 2020 atypical HUS therapeutic drug landscape, which includes a table containing in-depth links to pharmaceutical companies, research, and drug discovery information.
Part of the original content offered on this website, our 2020 overview provides detailed information about the future of atypical HUS drug development, while it uniquely conveys the interests and concerns from international aHUS advocacy and patient-centric viewpoints.
aHUS Alliance Overview of
2020 Atypical HUS Therapeutic Drug Development
(click link below)